Recombinant Norovirus tetravalent vaccine(hansenula polymorpha,Ncpc Genetech Biotech)
四价重组诺如病毒疫苗（汉逊酵母，华北制药金坦生物）
Report date: 2024/12/11 10:41:55
Base Information
Drug NameRecombinant Norovirus tetravalent vaccine(hansenula polymorpha,Ncpc Genetech Biotech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNcpc Genetech Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesNcpc Genetech Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A